Procedure

Mitochondrial Therapy in Navi Mumbai | Stem Rx IVF

Stem Rx IVF in Navi Mumbai offers mitochondrial therapy to support egg quality and cellular energy in reproductive medicine. Learn about approaches, candidacy, and risks.

Book a Consultation

Our team will get back to you within 2 hours

What is Mitochondrial Therapy for Fertility?

Mitochondrial therapy for fertility refers to a group of regenerative medicine interventions aimed at supporting the energy-producing function of mitochondria within egg cells (oocytes). Because mitochondrial activity directly influences egg quality and early embryo development, these approaches are being explored in reproductive medicine. Stem Rx IVF in Navi Mumbai offers mitochondrial therapy as part of its advanced fertility and reproductive medicine programme, under the care of Dr. Pallavi Lale (MBBS, MD – Obstetrics & Gynaecology).

Important: Mitochondrial therapy in the context of fertility is an evolving field. Some approaches remain experimental and are not yet standard clinical practice. A thorough consultation with a fertility specialist is essential before considering any mitochondrial intervention.

Mitochondria are often described as the cell's power generators. In oocytes, adequate mitochondrial function is critical for fertilisation, chromosomal division, and early embryo viability. Mitochondrial dysfunction — where these organelles produce insufficient energy — has been associated with poor egg quality, failed fertilisation, and recurrent implantation failure in IVF cycles.

Who may benefit from Mitochondrial Therapy?

Mitochondrial therapy is considered for patients where conventional fertility treatments have not achieved the desired outcome and where mitochondrial dysfunction may be a contributing factor. The following clinical presentations are typically evaluated:

  • Poor ovarian response — reduced number of eggs retrieved despite adequate stimulation
  • Diminished ovarian reserve — low egg count or reduced egg quality markers
  • Recurrent IVF failure — two or more failed IVF or ICSI cycles without a clear structural cause
  • Recurrent implantation failure — embryos that repeatedly fail to implant despite good morphology
  • Advanced maternal age — age-related decline in mitochondrial function within oocytes
  • Poor embryo development — embryos that arrest early or fail to reach blastocyst stage
  • Unexplained infertility — where standard investigations have not identified a cause

Warning: Suitability for mitochondrial therapy must be determined by a qualified fertility specialist following a full clinical assessment. Not every patient with the above presentations will be an appropriate candidate.

A detailed evaluation at Stem Rx IVF — including hormonal profiling, antral follicle count, and review of prior treatment history — is required to determine whether mitochondrial therapy is appropriate for an individual patient.

How is Mitochondrial Therapy performed at Stem Rx IVF?

The precise steps involved in mitochondrial therapy depend on the specific approach selected following clinical assessment. The general treatment pathway at Stem Rx IVF follows these stages:

  1. Initial Consultation & Assessment — Dr. Pallavi Lale reviews the patient's fertility history, prior IVF outcomes, hormonal profile, and ovarian reserve markers to establish whether mitochondrial dysfunction is a likely contributing factor.
  2. Diagnostic Workup — Relevant investigations are conducted, which may include detailed embryology review, ovarian reserve testing (AMH, AFC), and assessment of prior embryo development patterns.
  3. Treatment Planning — Based on findings, the clinical team determines the most appropriate mitochondrial intervention. The approach is individualised; no single protocol applies to all patients.
  4. Ovarian Stimulation (where applicable) — If the therapy is integrated into an IVF or ICSI cycle, controlled ovarian stimulation is initiated using standard gonadotropin protocols, with monitoring via ultrasound and blood tests.
  5. Egg Retrieval — Oocytes are collected under sedation using transvaginal ultrasound-guided aspiration, following standard IVF egg retrieval technique.
  6. Mitochondrial Intervention — The selected mitochondrial support approach is applied at the embryology laboratory stage, in conjunction with fertilisation (IVF or ICSI) and embryo culture.
  7. Embryo Culture & Assessment — Embryos are cultured and assessed for development quality. Blastocyst formation rates and morphology are monitored.
  8. Embryo Transfer — Suitable embryos are transferred to the uterus, or vitrified (frozen) for a subsequent frozen embryo transfer cycle.
  9. Post-Transfer Monitoring — Luteal phase support is provided. A serum beta-hCG test is performed approximately 14 days after transfer to assess for pregnancy.

For further information on how endometrial rejuvenation may complement mitochondrial therapy in preparing the uterine lining, speak with the clinical team.

What are the different mitochondrial therapy approaches used in fertility?

Several mitochondrial interventions have been investigated in reproductive medicine. The table below summarises the principal approaches, their current status, and key considerations. Stem Rx IVF evaluates each patient individually to determine which, if any, approach is clinically appropriate.

ApproachDescriptionCurrent StatusKey Consideration
Autologous Mitochondrial Transfer (AUGMENT)Transfer of mitochondria from the patient's own ovarian stem cells into her oocytesExperimental — limited clinical trial dataUses patient's own cells; avoids third-party genetic material
Cytoplasmic TransferInjection of cytoplasm (containing mitochondria) from a donor oocyte into the patient's eggRestricted in many countries including India; not standard practiceIntroduces donor mitochondrial DNA — regulatory and ethical considerations apply
Mitochondrial Replacement Therapy (MRT)Replacement of defective mitochondria in an egg with healthy donor mitochondria (spindle transfer or pronuclear transfer)Approved only in specific jurisdictions (e.g. UK for mitochondrial disease); not approved in India for fertility enhancementPrimarily indicated for preventing heritable mitochondrial disease, not routine infertility
Nutritional & Antioxidant SupportSupplementation with CoQ10, melatonin, and other mitochondria-supporting agents prior to IVF stimulationClinically used as adjunct; evidence is supportive but not conclusiveNon-invasive; often recommended as part of pre-IVF optimisation
Platelet-Rich Plasma (PRP) / Exosome TherapyRegenerative approaches that may support ovarian and mitochondrial function through growth factors and cellular signallingEmerging — under clinical investigationMay be used alongside IVF; see exosome therapy at Stem Rx IVF

Note: In India, mitochondrial replacement therapy involving donor mitochondrial DNA is not currently approved by the ICMR for routine fertility use. Stem Rx IVF follows applicable regulatory guidelines. The clinical team will advise on which approaches are permissible and appropriate for each patient.

What does recovery look like after Mitochondrial Therapy?

Recovery from mitochondrial therapy is largely determined by the associated procedure — most commonly an IVF or ICSI cycle. The following milestones apply to a standard treatment cycle that incorporates mitochondrial support:

  1. Day of Egg Retrieval — Rest is advised for the remainder of the day. Mild pelvic discomfort and bloating are common. Light activity may resume the following day.
  2. Days 1–5 (Embryo Culture Phase) — No physical procedure is required during this period. The embryology team monitors embryo development. Patients are advised to avoid strenuous exercise and alcohol.
  3. Day of Embryo Transfer — A straightforward outpatient procedure. Patients can typically return home within a few hours. Bed rest for the remainder of the day is generally recommended.
  4. Days 1–14 Post-Transfer (Two-Week Wait) — Luteal phase support medication (typically progesterone) is continued. Moderate activity is permitted; high-impact exercise and intercourse are usually avoided.
  5. Day 14 Post-Transfer — Serum beta-hCG blood test to assess for pregnancy. Results are reviewed with the clinical team.
  6. Ongoing Monitoring — If pregnancy is confirmed, early obstetric scans are scheduled. If the cycle is unsuccessful, a follow-up consultation is arranged to review outcomes and plan next steps.

If nutritional or antioxidant mitochondrial support is used as a standalone adjunct (without an IVF cycle), no procedural recovery period is required.

What are the risks and limitations of Mitochondrial Therapy?

Patients considering mitochondrial therapy should be aware of the following clinically relevant risks and limitations. These are discussed in detail during the consultation at Stem Rx IVF:

  • Experimental status — Several mitochondrial interventions remain investigational. Evidence from large randomised controlled trials is limited, and outcomes cannot be predicted with certainty.
  • No guaranteed improvement in IVF outcomes — Mitochondrial therapy does not assure improved fertilisation rates, embryo quality, or pregnancy. Individual responses vary.
  • Ovarian hyperstimulation syndrome (OHSS) — When combined with IVF stimulation, there is a risk of OHSS, ranging from mild bloating to, in rare cases, more significant fluid accumulation requiring medical attention.
  • Risks of egg retrieval — Transvaginal oocyte aspiration carries a small risk of bleeding, infection, or injury to adjacent structures.
  • Regulatory limitations in India — Certain mitochondrial techniques (particularly those involving donor mitochondrial DNA) are not approved for routine fertility use in India under current ICMR guidelines.
  • Ethical considerations — Techniques involving third-party genetic material raise ethical and legal questions that must be addressed prior to treatment.
  • Psychological impact — Undergoing experimental or advanced fertility treatment can be emotionally demanding. Counselling support is advisable throughout the process.
  • Cost — Advanced mitochondrial interventions may involve additional costs beyond a standard IVF cycle. Patients should discuss fees with the clinic before proceeding.

Who provides Mitochondrial Therapy at Stem Rx IVF?

Mitochondrial therapy at Stem Rx IVF in Navi Mumbai is provided within the Fertility & Reproductive Medicine speciality, under the care of:

DoctorQualificationsSpeciality
Dr. Pallavi LaleMBBS, MD – Obstetrics & GynaecologyFertility & Reproductive Medicine

To book a consultation with Dr. Pallavi Lale or to discuss whether mitochondrial therapy is appropriate for your situation, use the booking form on this page or contact the clinic directly.

Book a consultation at Stem Rx IVF

Use the booking form on this page, or reach out directly:

Call: +91 19152215415

WhatsApp: +919152215433

FAQs

  • Some mitochondrial support approaches — such as antioxidant supplementation, PRP, and autologous techniques — are available in India. However, mitochondrial replacement therapy involving donor mitochondrial DNA is not currently approved by the ICMR for routine fertility use. Stem Rx IVF in Navi Mumbai follows applicable regulatory guidelines and will advise on which approaches are permissible for your specific situation.
  • There is no single routine test that definitively diagnoses mitochondrial dysfunction in oocytes. However, patterns such as recurrent IVF failure, poor embryo development, or unexplained infertility may prompt further investigation. A fertility specialist at Stem Rx IVF will review your history, ovarian reserve markers, and prior embryology reports to assess whether mitochondrial factors may be relevant.
  • No. Mitochondrial therapy does not guarantee pregnancy or improved IVF outcomes. It is an adjunct intervention aimed at addressing a potential contributing factor to poor egg or embryo quality. The evidence base is still developing, and individual responses vary. Stem Rx IVF does not make outcome guarantees for any fertility treatment.
  • When integrated into an IVF or ICSI cycle, the overall process typically spans four to six weeks — from the start of ovarian stimulation through to the pregnancy test. Pre-treatment assessment and preparation may add additional time. If mitochondrial support is used as a standalone nutritional protocol, the timeline is determined by the supplementation period recommended before egg retrieval.
  • Mitochondrial therapy is a broad term covering various interventions that support mitochondrial function in oocytes, including nutritional support, autologous techniques, and regenerative approaches. Mitochondrial replacement therapy (MRT) specifically refers to replacing defective mitochondria with healthy donor mitochondria — a technique approved only in select jurisdictions for preventing heritable mitochondrial disease, not routine infertility treatment.
  • Yes. Where clinically appropriate, mitochondrial support approaches can be integrated into an IVF or ICSI treatment cycle at Stem Rx IVF in Navi Mumbai. The specific combination is determined on an individual basis by Dr. Pallavi Lale following a full assessment. Use the booking form on this page or contact the clinic via WhatsApp to discuss your options.

Get Expert Guidance — Speak with a Specialist Today

Our specialists will reach out within 24 hours with personalised advice tailored to your needs.


Prefer to talk now? with our team directly.

Contact Us Today